T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
67 hedge funds and large institutions have $8.02M invested in T2 Biosystems, Inc in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 5 closing their positions.
57% more call options, than puts
Call options by funds: $191K | Put options by funds: $122K
4% less funds holding
Funds holding: 70 → 67 (-3)
19% less capital invested
Capital invested by funds: $9.92M → $8.02M (-$1.89M)
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$115K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$27.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$27.6K |
| 4 |
Morgan Stanley
New York
|
+$27.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$27.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$703K |
| 2 |
Goldman Sachs
New York
|
-$694K |
| 3 |
Millennium Management
New York
|
-$187K |
| 4 |
VF
Virtu Financial
New York
|
-$108K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$74.3K |
TTOO Hedge Fund Activity: Q1 2022 in Review
67 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2022, worth a combined $8.02M — down 19% from $9.92M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TTOO and 2 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.
The largest buyer was Franklin Resources, adding an estimated $115K. The largest seller was Vanguard Group, cutting an estimated $703K.
- 67 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2022, down from 70 in Q4 2021.
- Funds reported $8.02M of T2 Biosystems, Inc stock for Q1 2022, down 19% quarter-over-quarter.
- 2 funds opened new T2 Biosystems, Inc positions in Q1 2022 and 5 closed out, a net change of -3 holders.
- The largest T2 Biosystems, Inc buyer in Q1 2022 was Franklin Resources, an estimated $115K added.
- The largest T2 Biosystems, Inc seller in Q1 2022 was Vanguard Group, an estimated $703K sold.
Based on aggregated 13F filings for Q1 2022.